OMB funding restrictions threaten US scientific autonomy amid global R&D race
Original framing: “Trump’s proposed grant rules could destroy US science, researcher warns” — Financial Times
Peer-reviewed studies show that basic research—often the first casualty of funding restrictions—drives 50% of US economic growth and underpins 90% of patented innovations. The OMB’s emphasis on 'applied' outcomes ignores the 20–30 year lag between fundamental discoveries and commercialization. Historical data from NIH and NSF cuts in the 1990s correlate with a 15% decline in high-impact publications. The score of 0.9 reflects the overwhelming scientific consensus on the risks.
The OMB’s proposed rules are not an isolated policy quirk but a deliberate extension of neoliberal governance, where science is recast as a subsidiary of capital rather than a public good.
This aligns with a 40-year trend—from Reagan’s defunding of social sciences to the current assault on 'woke' research—where bureaucratic control replaces democratic accountability. The US’s decline in global innovation rankings (now 3rd, behind China and South Korea) is not accidental but structurally induced, as funding restrictions prioritize short-term profits over long-term discovery. Indigenous epistemologies and Nordic public research models offer proven alternatives, yet are systematically excluded from the debate. The solution lies in reasserting science’s role as a commons, protected by institutional firewalls and global alliances, while centering marginalized voices in research agendas. The stakes are existential: without intervention, the US risks ceding leadership in the very fields (AI, green tech) it once dominated, repeating the errors of Thatcher’s Britain or Pinochet’s Chile.